NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
19/02/2026 08:58
NASDAQ TRADE HALT CONTINUES INTS.O REASON NOT AVAILABLE AT 03:58 AM
Recent news on Intensity Therapeutics
See all newsIntensity Therapeutics Q2 net loss widens as R&D costs rise
Brief: Intensity Therapeutics Q2 Operating Income USD -3.084 Million
Intensity Therapeutics Q1 net loss narrows on lower R&D costs
Brief: Intensity Therapeutics Q1 Operating Income USD -2.526 Million
Brief: Intensity Therapeutics Inc - Increases ATM Offering Capacity To $60 Million On March 23, 2026 - SEC Filing